| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K97651142 |
| PharmacoGx | BRD-K97651142 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NAGK | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-07 |
| mRNA | GBP3 | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-06 |
| mRNA | MEGF6 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-07 |
| mRNA | C19orf33 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-05 |
| mRNA | CHMP3 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-05 |
| mRNA | VASN | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | ATP6V0E1 | CTRPv2 | pan-cancer | AAC | -0.19 | 8e-06 |
| mRNA | EPS8L2 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-05 |
| mRNA | EHD2 | CTRPv2 | pan-cancer | AAC | -0.19 | 7e-06 |
| mRNA | FAM114A1 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-05 |
